A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.
暂无分享,去创建一个
Dieter Jocham | Georg Sczakiel | Hartmut Merz | Ingo Kausch | A. Feller | G. Sczakiel | H. Merz | D. Jocham | I. Kausch | Merle Hanke | Kai Hoefig | Alfred C Feller | Jens M Warnecke | Kai P Hoefig | J. Warnecke | M. Hanke
[1] W. Kassouf,et al. Biomarkers for detection and surveillance of bladder cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[2] Duan Ma,et al. The cell growth suppressor, mir-126, targets IRS-1. , 2008, Biochemical and biophysical research communications.
[3] Kishore Guda,et al. The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers , 2008, Genes, chromosomes & cancer.
[4] G. Nuovo,et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. , 2008, Biochemical and biophysical research communications.
[5] Joshua T. Mendell,et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.
[6] W. Gerald,et al. Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.
[7] D. Jocham,et al. Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancer. , 2007, Clinical chemistry.
[8] George A Calin,et al. Micro-RNA profiling in kidney and bladder cancers. , 2007, Urologic oncology.
[9] D. Valle,et al. MicroRNA (miRNA) Transcriptome of Mouse Retina and Identification of a Sensory Organ-specific miRNA Cluster* , 2007, Journal of Biological Chemistry.
[10] Stefanie Dimmeler,et al. Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis , 2007, Circulation research.
[11] Michael A. Beer,et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.
[12] M. Menon,et al. Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine , 2007, Proceedings of the National Academy of Sciences.
[13] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[14] L. Marks,et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. , 2006, Clinical chemistry.
[15] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[17] K. Miller,et al. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer , 2005, International journal of cancer.
[18] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[19] H. Razvi,et al. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. , 2004, The Canadian journal of urology.
[20] T. Fujioka,et al. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer. , 2002, The Journal of urology.
[21] H. Razvi,et al. Comparison of Human Telomerase Reverse Transcriptase Messenger RNA and Telomerase Activity as Urine Markers for Diagnosis of Bladder Carcinoma , 2000, Molecular Diagnosis.
[22] D. Swinkels,et al. Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas. , 2000, Clinical chemistry.
[23] D. Swinkels,et al. Detection of telomerase activity in urine as a tool for noninvasive detection of recurrent bladder tumors is poor and cannot be improved by timing of sampling. , 2000, Clinical chemistry.
[24] D. Swinkels,et al. Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas , 2000, International journal of cancer.
[25] D. Swinkels,et al. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. , 2000, Clinical chemistry.
[26] S. Kyo,et al. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] S. Kyo,et al. Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] K. Rieger-Christ,et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. , 2010, Urologic oncology.